We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find out about the long-term effects some people can have after having COVID-19.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
Guidance on acetic acid (also known as ethanoic acid) for use in responding to chemical incidents.
The review of the safety of isotretinoin has concluded.
Information relating to rare side effects after vaccination.
Information on methyl ethyl ketone (MEK) (also known as 2-butanone) for use in responding to chemical incidents.
Check what side effects people have reported when they've taken a medicine.
Information on acetone (also known as propanone) for use in responding to chemical incidents.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
FCDO travel advice for Ecuador. Includes safety and security, insurance, entry requirements and legal differences.
Information for patients, healthcare professionals and developers of new medicines
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
COMEAP statement on the evidence for differential health effects of particulate matter according to source or components.
Immediate and long term health effects of explosions and exposure to chemicals that occur during an explosion or fire.
Information on asbestos, for use in responding to chemical incidents.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).